XTL Biopharmaceuticals Ltd (XTLB)
1.28
+0.03
(+2.40%)
USD |
NASDAQ |
Mar 14, 16:00
XTL Biopharmaceuticals Price to Book Value: 1.973 for March 14, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Compugen Ltd | 2.810 |
| Pluri Inc | -- |
| BioLine Rx Ltd | 1.322 |
| Can Fite Biofarma Ltd | 4.008 |
| BiomX Inc | 0.5665 |
Price to Book Value Related Metrics
| Price | 1.28 |
| Earnings Yield | -15.62% |
| Market Cap | 11.28M |